# Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors.

> **NCT04283773** · — · COMPLETED · sponsor: **Assiut University** · enrollment: 62 (actual)

## Conditions studied

- Ovarian Neoplasms
- Germ Cell Tumors
- Immunohistochemistry

## Interventions

- **COMBINATION_PRODUCT:** p16INK4a Recombinant Rabbit Monoclonal Antibody (RM267)
- **COMBINATION_PRODUCT:** Ki67 antibody (DAKO) for malignant cases only

## Key facts

- **NCT ID:** NCT04283773
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-24
- **Primary completion:** 2021-04-01
- **Final completion:** 2021-04-01
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2021-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04283773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04283773, "Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors.". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT04283773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*